Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Robert Yang
Observed names:
R Yang,
R. Yang,
Robert Y. C. Yang,
Yang, Rob
Institutions:
Massachusetts General Hospital,
Center for Systems Biology,
Celgene (United States)
Observed institutions:
Harvard University,
Washington University in St. Louis,
Massachusetts General Hospital,
Center for Systems Biology,
Celgene (United States)
OpenAlex ID:
A5012007451
Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy
2017
·
Katherine S. Yang
, Hyungsoon Im
, et al.
·
Science Translational Medicine
·
296
PDF
Extracellular Vesicle Analysis Allows for Identification of Invasive IPMN
2020
·
Katherine S. Yang
, Debora Ciprani
, et al.
·
Gastroenterology
·
106
Dissecting Variability in Responses to Cancer Chemotherapy Through Systems Pharmacology
2010
·
R Yang
, M Niepel
, et al.
·
Clinical Pharmacology & Therapeutics
·
88
Targeting the Dimerization of Epidermal Growth Factor Receptors with Small‐Molecule Inhibitors
2010
·
Robert Y. C. Yang
, Katherine S. Yang
, et al.
·
Chemical Biology & Drug Design
·
39
PDF
Large-scale Analyses of Disease Biomarkers and Apremilast Pharmacodynamic Effects
2020
·
Irina V. Medvedeva
, Matthew E. Stokes
, et al.
·
Scientific Reports
·
21
PDF
15190 Whole blood transcriptomic profiling in a phase 3 study of the efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp
2020
·
Shaojun Tang
, Arnaud Amzallag
, et al.
·
Journal of the American Academy of Dermatology
Ab0527 Pharmacogenetics and Pharmacodynamics of Response to Apremilast in a Phase 3 Clinical Study in Subjects With Active Behçet's Disease
2020
·
J. Maranville
, I. Medvedeva
, et al.
·
Annals of the Rheumatic Diseases
Targeting The Dimerization Of ERBB Receptor Tyrosine Kinases
2009
·
Yang, Rob
·
Open Scholarship Institutional Repository (Washington University in St. Louis)
PDF
Show more works
View as search
Works count:
8
Citation count:
550
H-index:
5
I10-index:
5
Year
Topic
Type